Skip Navigation LinksHome > October 2012 - Volume 46 - Issue > Microbes On-Air: Gut and Tissue Microbiota as Targets in Typ...
Journal of Clinical Gastroenterology:
doi: 10.1097/MCG.0b013e318264e844

Microbes On-Air: Gut and Tissue Microbiota as Targets in Type 2 Diabetes

Serino, Matteo PhD*,†; Blasco-Baque, Vincent MD*,†,‡; Burcelin, Remy PhD*,†

Collapse Box


Each individual can be distinguished by the heterogeneity of the trillions of microbes inhabiting his gastrointestinal tract. This concept, together with the role that gut microbiota is considered to play in the induction of metabolic diseases, paves the way for the development of personalized medicine. By exploiting our unique animal model of metabolic adaptation to a high-fat diet, we have recently shown that differential gut microbiota lead to different metabolic phenotypes—metabotypes. Moreover, we have also reported that a given metabotype can be distinguished by different profiles of gut microbes, symptomatic of the complexity of the regulation of host physiology by gut microbiota. Furthermore, in an effort to find bacterial predictors of type 2 diabetes (T2D), we discovered that in a healthy population, subjects who subsequently developed T2D had increased blood levels of bacterial 16S rDNA well before. In addition, tissue (blood) microbiota, mainly characterized by Proteobacteria (up to 90%), has been discovered both in healthy individuals and in diabetic patients. Altogether, our results confirm the presence of gut microbes and propose tissue microbiota as new targets for the innovative treatment of T2D.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.